Literature DB >> 8939773

Vitamin K2 promotes 1alpha,25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts.

Y Koshihara1, K Hoshi, H Ishibashi, M Shiraki.   

Abstract

The effect of vitamin K on mineralization by human periosteal osteoblasts was investigated in the absence and presence of 1alpha, 25 dihydroxyvitamin D3 (1,25(OH)2D3). Vitamin K1 and K2, but not vitamin K3, at 2.5 microM enhanced in vitro mineralization when cells were cultured with vitamin K for 20 days after reaching confluence in vitro. Vitamin K2 (2-methyl-3-all-trans-tetraphenyl-1, 4-naphthoquinone : menatetrenone) was the most potent of these vitamin K analogs; it slightly inhibited alkaline phosphatase (ALP) activity. Human osteoblasts were mineralized and showed the enhanced ALP activity on treatment with 10(-9) M of 1,25(OH)2D3 for 20 or 25 days after confluence. Vitamin K2 promoted the 1,25(OH)2D3-induced mineralization, but slightly inhibited the 1,25(OH)2D3-induced ALP activity. Moreover, vitamin K2 enhanced the 1,25(OH)2D3-induced osteocalcin accumulation in the cells and the extracellular matrix (cell layer), but inhibited the osteocalcin content in the medium produced by the 1,25(OH)2D3 treatment. However, vitamin K2 alone did not induce osteocalcin production in the human osteoblasts. On Northern blot analysis, osteocalcin mRNA expression on 1, 25(OH)2D3-treated cells was enhanced by vitamin K2 treatment, but vitamin K2 alone did not induce osteocalcin mRNA expression. Warfarin blocked both the 1,25(OH)2D3-induced osteocalcin production and the accumulation in the cell layer, and also blocked the 1, 25(OH)2D3 plus vitamin K2-induced osteocalcin production and the accumulation in the cell layer. The 1,25(OH)2D3-induced mineralization promoted by vitamin K2 was probably due to the enhanced accumulation of osteocalcin induced by vitamin K2 in the cell layer. However, we concluded that the mineralization induced by vitamin K2 alone was due to the accumulation of osteocalcin in bovine serum on the cell layer, since osteocalcin extracted from the cell layer was not identified by specific antiserum against human osteocalcin, which does not cross-react with bovine osteocalcin. These results suggest that the mechanism underlying the mineralization induced by vitamin K2 in the presence of 1,25(OH)2D3 was different from that of vitamin K2 alone, and that osteocalcin plays an important role in mineralization by osteoblasts in vitro.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8939773     DOI: 10.1007/bf00369212

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  27 in total

1.  Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women.

Authors:  P Szulc; M C Chapuy; P J Meunier; P D Delmas
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

2.  Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone.

Authors:  P A Price; M K Williamson; J W Lothringer
Journal:  J Biol Chem       Date:  1981-12-25       Impact factor: 5.157

3.  In vitro calcification in human osteoblastic cell line derived from periosteum.

Authors:  Y Koshihara; M Kawamura; H Oda; S Higaki
Journal:  Biochem Biophys Res Commun       Date:  1987-06-15       Impact factor: 3.575

4.  Protein-S, a vitamin K-dependent protein, is a bone matrix component synthesized and secreted by osteoblasts.

Authors:  C Maillard; M Berruyer; C M Serre; M Dechavanne; P D Delmas
Journal:  Endocrinology       Date:  1992-03       Impact factor: 4.736

5.  Differential effects of warfarin on mRNA levels of developmentally regulated vitamin K dependent proteins, osteocalcin, and matrix GLA protein in vitro.

Authors:  L M Barone; M A Aronow; M S Tassinari; D Conlon; E Canalis; G S Stein; J B Lian
Journal:  J Cell Physiol       Date:  1994-08       Impact factor: 6.384

6.  Evidence for vitamin D dependent gamma-carboxylation in osteocalcin related proteins.

Authors:  Z Deyl; M Adam
Journal:  Biochem Biophys Res Commun       Date:  1983-05-31       Impact factor: 3.575

7.  Primary structure of bovine matrix Gla protein, a new vitamin K-dependent bone protein.

Authors:  P A Price; M K Williamson
Journal:  J Biol Chem       Date:  1985-12-05       Impact factor: 5.157

8.  Characterization of human bone cells in culture.

Authors:  B Auf'mkolk; P V Hauschka; E R Schwartz
Journal:  Calcif Tissue Int       Date:  1985-05       Impact factor: 4.333

9.  Secretion of osteocalcin and its propeptide from human osteoblastic cells: dissociation of the secretory patterns of osteocalcin and its propeptide.

Authors:  K Hosoda; S Kanzaki; H Eguchi; M Kiyoki; T Yamaji; Y Koshihara; M Shiraki; Y Seino
Journal:  J Bone Miner Res       Date:  1993-05       Impact factor: 6.741

10.  Osteocalcin induces chemotaxis, secretion of matrix proteins, and calcium-mediated intracellular signaling in human osteoclast-like cells.

Authors:  C Chenu; S Colucci; M Grano; P Zigrino; R Barattolo; G Zambonin; N Baldini; P Vergnaud; P D Delmas; A Z Zallone
Journal:  J Cell Biol       Date:  1994-11       Impact factor: 10.539

View more
  15 in total

1.  The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial.

Authors:  S H Rønn; T Harsløf; L Oei; S B Pedersen; B L Langdahl
Journal:  Osteoporos Int       Date:  2020-10-08       Impact factor: 4.507

2.  Effect of vitamin K2 on the development of stress-induced osteopenia in a growing senescence-accelerated mouse prone 6 strain.

Authors:  Hironobu Katsuyama; Shigeko Fushimi; Kunikazu Yamane; Yoko Watanabe; Koichiro Shimoya; Toshiko Okuyama; Midori Katsuyama; Kiyofumi Saijoh; Masafumi Tomita
Journal:  Exp Ther Med       Date:  2015-07-07       Impact factor: 2.447

3.  Serum level of under-carboxylated osteocalcin and bone mineral density in early menopausal Norwegian women.

Authors:  Nina Emaus; Nguyen D Nguyen; Bjørg Almaas; Gro K Berntsen; Jacqueline R Center; Monika Christensen; Clara G Gjesdal; Anne S Grimsgaard; Tuan V Nguyen; Laila Salomonsen; John A Eisman; Vinjar M Fønnebø
Journal:  Eur J Nutr       Date:  2011-11-30       Impact factor: 5.614

4.  Increased Consumption of Plant Foods Is Associated with Increased Bone Mineral Density.

Authors:  J Berg; N Seyedsadjadi; R Grant
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 4.075

5.  The effect of adsorbed vitamin D and K to hydroxyapatite on ALP activity of MC3T3-E1 cell.

Authors:  K Ozeki; H Aoki; Y Fukui
Journal:  J Mater Sci Mater Med       Date:  2007-10-18       Impact factor: 3.896

6.  Effects of combination treatment with alendronate and vitamin K(2) on bone mineral density and strength in ovariectomized mice.

Authors:  Hiroshi Sasaki; Naohisa Miyakoshi; Yuji Kasukawa; Shigeto Maekawa; Hideaki Noguchi; Keji Kamo; Yoichi Shimada
Journal:  J Bone Miner Metab       Date:  2010-01-26       Impact factor: 2.626

Review 7.  Natural medicine delivery from biomedical devices to treat bone disorders: A review.

Authors:  Susmita Bose; Naboneeta Sarkar; Dishary Banerjee
Journal:  Acta Biomater       Date:  2021-02-28       Impact factor: 8.947

8.  Prior treatment with vitamin K(2) significantly improves the efficacy of risedronate.

Authors:  Y Matsumoto; Y Mikuni-Takagaki; Y Kozai; K Miyagawa; K Naruse; H Wakao; R Kawamata; I Kashima; T Sakurai
Journal:  Osteoporos Int       Date:  2009-03-12       Impact factor: 4.507

9.  Vitamin K: an old vitamin in a new perspective.

Authors:  U Gröber; J Reichrath; M F Holick; K Kisters
Journal:  Dermatoendocrinol       Date:  2015-01-21

10.  Reduced bone resorption by intake of dietary vitamin D and K from tailor-made Atlantic salmon: A randomized intervention trial.

Authors:  Ingvild Eide Graff; Jannike Øyen; Marian Kjellevold; Livar Frøyland; Clara Gram Gjesdal; Bjørg Almås; Grethe Rosenlund; Øyvind Lie
Journal:  Oncotarget       Date:  2016-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.